The Effect of Human Mesenchymal Stem Cells-Conditioned Media on Glioblastoma Cells Viability In Vitro

Area of Science:

• Oncology
• Stem Cell Biology
• Cancer Research

Background:

• Mesenchymal stem cells (MSCs) have a controversial role in cancer, with studies showing both inhibition and promotion of tumor growth.
• Understanding the specific effects of different MSC sources, such as umbilical cord (hUC-MSCs) and bone marrow (hBM-MSCs), is crucial for targeted cancer therapies.

Purpose of the Study:

• To investigate the in vitro effects of conditioned media from human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) and bone marrow-derived mesenchymal stem cells (hBM-MSCs) on glioblastoma (GB) cell viability.
• To determine the differential impact of MSCs from distinct tissue origins on glioblastoma cell proliferation and survival.

Main Methods:

• Glioblastoma (GB) cell cultures were established from patient samples.
• Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) and bone marrow-derived mesenchymal stem cells (hBM-MSCs) were utilized.
• GB cells were treated with conditioned media (CM) from MSCs for varying durations (24-96 hours).
• MTT cell proliferation assay was employed to assess cell viability, with statistical analysis using Student's t-test.

Main Results:

• Conditioned media from hUC-MSCs exhibited cytotoxic effects on glioblastoma cells, inhibiting their proliferation.
• Treatment with hBM-MSCs conditioned media initially stimulated GB cell growth at 24 hours.
• hBM-MSCs conditioned media showed a minor inhibitory effect on GB cell growth at later time points (48, 72, and 96 hours).

Conclusions:

• hUC-MSCs demonstrate potential as an anti-cancer agent by inhibiting glioblastoma cell proliferation.
• hBM-MSCs have a dual effect, initially promoting and later slightly inhibiting glioblastoma cell growth, indicating context-dependent roles.
• The source of mesenchymal stem cells significantly influences their therapeutic potential in glioblastoma treatment.